Log in
Log in
Or log in with
GoogleGoogle
Twitter Twitter
Facebook Facebook
Apple Apple     
Sign up
Or log in with
GoogleGoogle
Twitter Twitter
Facebook Facebook
Apple Apple     

LEMAITRE VASCULAR, INC.

(LMAT)
  Report
Real-time Estimate Cboe BZX  -  12:38:07 2023-02-08 pm EST
48.85 USD   -0.69%
2022LeMaitre to Present at Upcoming Investor Conferences
AQ
2022LEMAITRE VASCULAR, INC. : Ex-dividend day for
FA
2022LEMAITRE VASCULAR INC Management's Discussion and Analysis of Financial Condition and Results of Operations (form 10-Q)
AQ
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisionsFunds 
Valuation
Fiscal Period: December 2019 2020 2021 2022 2023 2024
Capitalization1 7198241 0971 0821 082-
Enterprise Value (EV)1 7198241 0971 0821 0821 082
P/E ratio 40,9x38,9x40,2x52,9x41,4x35,7x
Yield --0,88%1,02%1,02%-
Capitalization / Revenue 6,13x6,37x7,10x6,69x6,32x5,90x
EV / Revenue 6,13x6,37x7,10x6,69x6,32x5,90x
EV / EBITDA 27,2x22,5x24,0x27,8x24,0x20,1x
Enterprise Value (EV) / FCF 69,0x25,9x36,3x47,0x31,9x27,9x
FCF Yield 1,45%3,86%2,75%2,13%3,14%3,59%
Price to Book ------
Nbr of stocks (in thousands) 19 99120 34221 83822 00122 001-
Reference price (USD) 36,040,550,249,249,249,2
Announcement Date 02/06/202002/25/202102/24/2022---
1 USD in Million
Previous periodNext period
Estimates
Income Statement Evolution (Annual data)
Fiscal Period: December 2019 2020 2021 2022 2023 2024
Net sales1 117129154162171183
EBITDA1 26,436,745,838,945,053,8
Operating profit (EBIT)1 21,228,836,427,734,840,7
Operating Margin 18,1%22,3%23,6%17,2%20,3%22,2%
Pre-Tax Profit (EBT)1 21,727,434,327,235,040,8
Net income1 17,921,226,920,726,631,2
Net margin 15,3%16,4%17,4%12,8%15,6%17,0%
EPS2 0,881,041,250,931,191,38
Free Cash Flow1 10,431,830,223,034,038,9
FCF margin 8,89%24,6%19,6%14,2%19,8%21,2%
FCF Conversion 39,5%86,7%66,0%59,2%75,5%72,3%
Dividend per Share2 --0,440,500,50-
Announcement Date 02/06/202002/25/202102/24/2022---
1 USD in Million
2 USD
Previous periodNext period
Estimates
Income Statement Evolution (Quarterly data)
Fiscal Period: December 2022 Q1 2022 Q2 2022 Q3 2022 Q4 2023 Q1 2023 Q2
Net sales1 39,642,139,041,040,944,8
EBITDA1 10,311,38,2110,08,9010,6
Operating profit (EBIT)1 7,938,896,157,447,659,53
Operating Margin 20,0%21,1%15,8%18,2%18,7%21,3%
Pre-Tax Profit (EBT)1 8,005,556,157,447,699,57
Net income1 6,043,525,465,725,847,25
Net margin 15,3%8,35%14,0%13,9%14,3%16,2%
EPS2 0,270,160,250,260,260,33
Dividend per Share2 0,130,130,130,130,130,13
Announcement Date 04/28/202207/28/202210/27/2022---
1 USD in Million
2 USD
Previous periodNext period
Estimates
Balance Sheet Analysis
Fiscal Period: December 2019 2020 2021 2022 2023 2024
Net Debt ------
Net Cash position ------
Leverage (Debt / EBITDA) ------
Free Cash Flow1 10,431,830,223,034,038,9
ROE (Net Profit / Equities) 12,9%13,2%12,6%8,45%9,95%10,7%
Shareholders' equity1 139160213244268293
ROA (Net Profit / Asset) 10,5%9,62%9,86%7,40%8,70%9,40%
Assets1 171221273279306331
Book Value Per Share ------
Cash Flow per Share ------
Capex1 3,762,984,883,704,454,75
Capex / Sales 3,21%2,31%3,16%2,29%2,60%2,59%
Announcement Date 02/06/202002/25/202102/24/2022---
1 USD in Million
Previous periodNext period
Estimates
Key data
Capitalization (USD) 1 082 223 287
Net sales (USD) 154 424 000
Number of employees 469
Sales / Employee (USD) 329 262
Free-Float 82,5%
Free-Float capitalization (USD) 893 322 564
Avg. Exchange 20 sessions (USD) 3 575 439
Average Daily Capital Traded 0,33%
EPS & Dividend
Year-on-year evolution of the PER
Year-on-year evolution of the Yield
Change in Enterprise Value/EBITDA